Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andy Singh"'
Autor:
Mark E. Robson, Betty Ann Caravella, Mario E. Lacouture, Helen Won, Richard B. Lanman, M. Scaltriti, Neil Vasan, David B. Solit, Payal D. Shah, Aimee Cowan, Maura N. Dickler, Shanu Modi, Ronglai Shen, Elizabeth A. Comen, Weiyi Toy, Bob T. Li, Anne M. Covey, Komal Jhaveri, Sujata Patil, Jorge S. Reis-Filho, Rebecca J. Nagy, Pier Selenica, Pedram Razavi, Michael F. Berger, Stephen Zamora, Larry Norton, Mary Ellen Moynahan, Justin I. Odegaard, David N Brown, Clifford A. Hudis, Edi Brogi, Sarat Chandarlapaty, Andy Singh
Publikováno v:
Nature Cancer. 1:382-393
Alpelisib is a selective inhibitor of PI3Kα, shown to improve outcomes for PIK3CA mutant, hormone receptor positive (HR+) metastatic breast cancers (MBC) when combined with antiestrogen therapy. To uncover mechanisms of resistance, we conducted a de
Autor:
Pedram, Razavi, Maura N, Dickler, Payal D, Shah, Weiyi, Toy, David N, Brown, Helen H, Won, Bob T, Li, Ronglai, Shen, Neil, Vasan, Shanu, Modi, Komal, Jhaveri, Betty Ann, Caravella, Sujata, Patil, Pier, Selenica, Stephen, Zamora, Aimee M, Cowan, Elizabeth, Comen, Andy, Singh, Anne, Covey, Michael F, Berger, Clifford A, Hudis, Larry, Norton, Rebecca J, Nagy, Justin I, Odegaard, Richard B, Lanman, David B, Solit, Mark E, Robson, Mario E, Lacouture, Edi, Brogi, Jorge S, Reis-Filho, Mary Ellen, Moynahan, Maurizio, Scaltriti, Sarat, Chandarlapaty
Publikováno v:
Nat Cancer
Alpelisib is a selective inhibitor of PI3Kα, shown to improve outcomes for PIK3CA mutant, hormone receptor positive (HR+) metastatic breast cancers (MBC) when combined with antiestrogen therapy. To uncover mechanisms of resistance, we conducted a de
Publikováno v:
International journal of cancer. 90(5)
Purpose To evaluate the efficacy and morbidity of combined 3-dimensional conformal radiation therapy (3D-CRT) and brachytherapy for intermediate/unfavorable risk prostate cancer. Materials and Methods Between May 1996 and November 1997, 65 patients w